2021-2022 EEH Enduring Program: COVID-19 Updates in Pulmonology and Pathophysiology


2021-2022 EEH Enduring Program: COVID-19 Updates in Pulmonology and Pathophysiology Banner

Course Instructions

Registration

Registration is not required for this online event.  However, due to requirements of our CME accreditation, credits are not applied until the Post-Test and evaluation/follow-up survey are completed.

Release date: March 18, 2021                   Expiration date:  March 18, 2022

Completion Requirements:  To gain credit for this online activity, participants must view the entire video, complete the post-test with a 100% pass rate, and complete the evaluation and follow-up survey. Participants will have one attempt to complete the post-test.

Technology Requirements:  Participants will need a computer with access to the internet and sound to complete this course.

Estimated Completion Time: 45 minutes


Date & Location
Thursday, March 18, 2021, 8:00 AM - Friday, March 18, 2022, 8:45 AM, Online Enduring

Overview
Over the last two decades, the coronavirus family has been identified as the source of several highly pathogenic global outbreaks. The recent coronavirus-2 (SARS-CoV-2) has been identified as the culprit of the recent, highly infectious outbreak. As the COVID-19 exhibits similar to the 2003 Severe Acute Respiratory Syndrome (SARS), clinical manifestation most commonly presents in the pulmonary system. Treatment can vary depending on the infected individuals symptoms which range from mild to severe. Two kinds of tests are available for COVID-19: viral tests and antibody tests. This live activity is designed to review the latest pulmonology and pathology findings on treatment and testing for COVID-19.

Objectives
At the conclusion of this activity, participants should be able to: 

  1. 1. Identify the respiratory manifestations of COVID-19.
  2. 2. Evaluate the predictors of worsened respiratory outcomes caused by COVID-19.
  3. 3. Identify indications for outpatient management of respiratory symptoms of COVID-19 including if/when steroids should be used.
  4. 4. Review the inpatient management of severe respiratory disease in COVID
  5. 5. Review the viral structure of the SARS-CoV-2 virus and how it relates to transmission dynamics and testing.
  6. 6. Compare rapid and standard PCR-based assays for the diagnosis of COVID-19.
  7. 7. Discuss the differences between antigen and antibody testing for COVID-19.
  8. 8. Review combination testing and discuss CDC testing recommendations

Target Audience
Specialties - Emergency Medicine, Family Medicine, Medicine and Medicine Subspecialties, Multidisciplinary Healthcare
Professions - Advanced Practice Provider, Clinical Support Staff, Physician

Credits
AMA PRA Category 1 Credits™ (0.75 hours), Non-Physician Attendance (0.75 hours)

Accreditation
Edward-Elmhurst Health is accredited by the Illinois State Medical Society (ISMS) to provide Continuing Medical Education credit to physicians.  

Edward-Elmhurst Health designates this Enduring Material for a maximum of 0.75 AMA PRA Category 1 CreditTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Disclosures
Disclosures:

No one involved in the approval, planning, or presentation of this activity has disclosed any relevant conflict of any interest with any commercial entity.